Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heparanase and the hallmarks of cancer
Krishnath M. Jayatilleke, Mark D. Hulett
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 362
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
Mohammad Javed Ansari, Dmitry Olegovich Bokov, Alexander Markov, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 130
Cancer metastasis: Molecular mechanisms and clinical perspectives
Sameer Ullah Khan, Kaneez Fatima, Fayaz Malik, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108522-108522
Closed Access | Times Cited: 60
A biological guide to glycosaminoglycans: current perspectives and pending questions
Sylvie Ricard‐Blum, Romain R. Vivès, Liliana Schaefer, et al.
FEBS Journal (2024) Vol. 291, Iss. 15, pp. 3331-3366
Open Access | Times Cited: 25
Anticancer Effects with Molecular Docking Confirmation of Newly Synthesized Isatin Sulfonamide Molecular Hybrid Derivatives against Hepatic Cancer Cell Lines
Mahmoud Eldeeb, Eman F. Sanad, Ahmed Ragab, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 722-722
Open Access | Times Cited: 55
Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug—A Review
Jun‐O Jin, Dhananjay Yadav, Kajal Madhwani, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6032-6032
Open Access | Times Cited: 45
Immune Cell Migration to Cancer
Allison Ryan, Minsoo Kim, Kihong Lim
Cells (2024) Vol. 13, Iss. 10, pp. 844-844
Open Access | Times Cited: 12
The Emerging Role of Neutrophil Extracellular Traps in Arterial, Venous and Cancer-Associated Thrombosis
Yilu Zhou, Weimin Tao, Fuyi Shen, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 41
Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo
Casper de Boer, Zachary Armstrong, Vincent A. J. Lit, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 31
Heparanase—A single protein with multiple enzymatic and nonenzymatic functions
Israël Vlodavsky, Yasmin Kayal, Maram Hilwi, et al.
Proteoglycan Research (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 18
Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms
Israël Vlodavsky, Maram Hilwi, Yasmin Kayal, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Open Access | Times Cited: 6
CAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
The Heparanase Regulatory Network in Health and Disease
Alyce J. Mayfosh, Tien Nguyen, Mark D. Hulett
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11096-11096
Open Access | Times Cited: 33
Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review
Artur Słomka, Miroslaw Kornek, William C. Cho
Cells (2022) Vol. 11, Iss. 18, pp. 2913-2913
Open Access | Times Cited: 26
The feedback regulator Nord controls Dpp/BMP signaling via extracellular interaction with Dally in the Drosophila wing
Takuya Akiyama, Chris Seidel, Matthew C. Gibson
Developmental Biology (2022) Vol. 488, pp. 91-103
Open Access | Times Cited: 23
Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies
Ram Kumar Sahu, Sakina Ruhi, Ashok Kumar Jeppu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Treatment with semaglutide, a GLP-1 receptor agonist, improves extracellular matrix remodeling in the pancreatic islet of diet-induced obese mice
Luiz E.M. Cardoso, Thatiany de Souza Marinho, Fabiane Ferreira Martins, et al.
Life Sciences (2023) Vol. 319, pp. 121502-121502
Closed Access | Times Cited: 15
Transition metals in angiogenesis – A narrative review
J. R. Durig, Maurizio Calcagni, Johanna Buschmann
Materials Today Bio (2023) Vol. 22, pp. 100757-100757
Open Access | Times Cited: 13
Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study
Yuzhao Zhang, Meijun Xiong, Zixin Chen, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 7, pp. 1032-1040
Closed Access | Times Cited: 5
Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management
Isabel Faria‐Ramos, Juliana Poças, Catarina Marques, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 136-136
Open Access | Times Cited: 29
Ten Years of Research on Fucoidan and Cancer: Focus on Its Antiangiogenic and Antimetastatic Effects
Eleonora Turrini, Francesca Maffei, Carmela Fimognari
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 307-307
Open Access | Times Cited: 11
Targeted therapy for multiple myeloma: an overview on CD138-based strategies
Federico Riccardi, Carmela Tangredi, Michele Dal Bo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Development of folate receptor targeting chimeras for cancer selective degradation of extracellular proteins
Yaxian Zhou, Chunrong Li, Xuankun Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study
Chengjun Li, Xiaomeng Cui, Mudan Ren, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor Activity
Jasmine Holail, Hatouf H. Sukkarieh, Ahmad Aljada
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 396-396
Open Access
Page 1 - Next Page

Scroll to top